Jinling Jiang

1.5k total citations
75 papers, 1.1k citations indexed

About

Jinling Jiang is a scholar working on Molecular Biology, Oncology and Control and Systems Engineering. According to data from OpenAlex, Jinling Jiang has authored 75 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 21 papers in Oncology and 17 papers in Control and Systems Engineering. Recurrent topics in Jinling Jiang's work include Fault Detection and Control Systems (13 papers), Control Systems and Identification (9 papers) and Advanced Control Systems Optimization (6 papers). Jinling Jiang is often cited by papers focused on Fault Detection and Control Systems (13 papers), Control Systems and Identification (9 papers) and Advanced Control Systems Optimization (6 papers). Jinling Jiang collaborates with scholars based in China, Canada and Denmark. Jinling Jiang's co-authors include Qu Cai, Jun Zhang, R. Doraiswami, Min Shi, Yingyan Yu, Zhenggang Zhu, Jun Ji, Zhenggang Zhu, Bruce T. Liang and Kenneth A. Jacobson and has published in prestigious journals such as IEEE Transactions on Automatic Control, Oncogene and Scientific Reports.

In The Last Decade

Jinling Jiang

68 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinling Jiang China 18 454 348 252 238 94 75 1.1k
Bo Sun China 22 763 1.7× 390 1.1× 155 0.6× 122 0.5× 247 2.6× 55 1.6k
Yen‐Yu Lu Taiwan 18 592 1.3× 118 0.3× 532 2.1× 151 0.6× 82 0.9× 60 1.8k
Sihua Wang China 25 500 1.1× 217 0.6× 223 0.9× 194 0.8× 26 0.3× 101 1.9k
Kangjie Chen China 21 379 0.8× 240 0.7× 365 1.4× 65 0.3× 45 0.5× 44 1.2k
Shuguang Huang United States 19 655 1.4× 205 0.6× 221 0.9× 77 0.3× 17 0.2× 66 1.2k
Jungwoon Lee South Korea 20 799 1.8× 233 0.7× 163 0.6× 69 0.3× 50 0.5× 49 1.3k
Jinjun Rao China 17 947 2.1× 658 1.9× 608 2.4× 735 3.1× 96 1.0× 76 2.2k
Can Hu China 17 443 1.0× 197 0.6× 308 1.2× 279 1.2× 15 0.2× 95 1.1k
Boning Liu China 20 575 1.3× 292 0.8× 238 0.9× 74 0.3× 35 0.4× 53 1.2k
Ken Fukuda Japan 19 827 1.8× 75 0.2× 129 0.5× 100 0.4× 28 0.3× 103 1.6k

Countries citing papers authored by Jinling Jiang

Since Specialization
Citations

This map shows the geographic impact of Jinling Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinling Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinling Jiang more than expected).

Fields of papers citing papers by Jinling Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinling Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinling Jiang. The network helps show where Jinling Jiang may publish in the future.

Co-authorship network of co-authors of Jinling Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Jinling Jiang. A scholar is included among the top collaborators of Jinling Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinling Jiang. Jinling Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Seok‐Seong, Hao Huang, Zhiying Miao, et al.. (2025). Discovery of anti-tumor targets based on photo-affinity labeling. European Journal of Medicinal Chemistry. 301. 118248–118248.
2.
Wang, Chao, Benyan Zhang, Jun Ji, et al.. (2024). Blocking EGR1/TGF-β1 and CD44s/STAT3 Crosstalk Inhibits Peritoneal Metastasis of Gastric Cancer. International Journal of Biological Sciences. 20(4). 1314–1331. 9 indexed citations
3.
Zhou, Chenfei, Jinling Jiang, Xiaojun Xiang, et al.. (2024). Preclinical investigations and a first-in-human phase 1a trial of JS007, a novel anti-CTLA-4 antibody, in patients with advanced solid tumors. Experimental Hematology and Oncology. 13(1). 98–98. 1 indexed citations
4.
Chen, Yong, Jinling Jiang, Chao Yan, et al.. (2024). Prediction of tumor regression grade in far-advanced gastric cancer after preoperative immuno-chemotherapy using dual-energy CT-derived extracellular volume fraction. European Radiology. 35(1). 93–104. 6 indexed citations
6.
Zhou, Qingqing, Chenfei Zhou, Jun Ji, et al.. (2023). VPS35 promotes gastric cancer progression through integrin/FAK/SRC signalling-mediated IL-6/STAT3 pathway activation in a YAP-dependent manner. Oncogene. 43(2). 106–122. 15 indexed citations
7.
Liu, Tengfei, Wenjing Qian, Jun Ji, et al.. (2023). HNF4A-BAP31-VDAC1 axis synchronously regulates cell proliferation and ferroptosis in gastric cancer. Cell Death and Disease. 14(6). 29 indexed citations
8.
Cai, Qu, Lingling Wang, Jun Ji, et al.. (2023). Paracrine activin B-NF-κB signaling shapes an inflammatory tumor microenvironment in gastric cancer via fibroblast reprogramming. Journal of Experimental & Clinical Cancer Research. 42(1). 269–269. 12 indexed citations
9.
Guo, Meng-Hao, Jinling Jiang, Xiaoran Yan, et al.. (2023). Investigations on Scientific Literature Meta Information Extraction Using Large Language Models. 249–254. 1 indexed citations
10.
Zhou, Chenfei, Jun Ji, Wenqi Xi, et al.. (2023). Plasma Exosome Proteins ILK1 and CD14 Correlated with Organ-Specific Metastasis in Advanced Gastric Cancer Patients. Cancers. 15(15). 3986–3986. 7 indexed citations
11.
Wang, Nan, Wenqi Xi, Sheng Lu, et al.. (2021). A Novel Inflammatory-Nutritional Prognostic Scoring System for Stage III Gastric Cancer Patients With Radical Gastrectomy Followed by Adjuvant Chemotherapy. Frontiers in Oncology. 11. 650562–650562. 20 indexed citations
12.
Jiang, Jinling, Wenqi Xi, Junwei Wu, et al.. (2020). Postoperative BMI Loss at One Year Correlated with Poor Outcomes in Chinese Gastric Cancer Patients. International Journal of Medical Sciences. 17(15). 2276–2284. 17 indexed citations
13.
Wang, Chao, Wenqi Xi, Jun Ji, et al.. (2020). The prognostic value of HGF-c-MET signaling pathway in Gastric Cancer: a study based on TCGA and GEO databases. International Journal of Medical Sciences. 17(13). 1946–1955. 11 indexed citations
14.
Wang, Chao, Min Shi, Jun Ji, et al.. (2019). A self-enforcing HOXA11/Stat3 feedback loop promotes stemness properties and peritoneal metastasis in gastric cancer cells. Theranostics. 9(25). 7628–7647. 19 indexed citations
15.
Wang, Chao, Chen Yang, Jun Ji, et al.. (2017). Deubiquitinating enzyme USP20 is a positive regulator of claspin and suppresses the malignant characteristics of gastric cancer cells. International Journal of Oncology. 50(4). 1136–1146. 31 indexed citations
16.
Jiang, Jinling, et al.. (2015). Detection of Perlger-Huet anomaly based on augmented fast marching method and speeded up robust features. Bio-Medical Materials and Engineering. 26(1_suppl). S1241–8. 1 indexed citations
17.
Ma, Tao, et al.. (2014). Preparation and evaluation of nanoparticles loading plasmid DNAs inserted with siRNA fragments targeting c-Myc gene. Pharmaceutical Biology. 52(9). 1179–1188. 4 indexed citations
18.
Shi, Hailong, Jinling Jiang, Jun Ji, et al.. (2014). Anti-angiogenesis participates in antitumor effects of metronomic capecitabine on colon cancer. Cancer Letters. 349(2). 128–135. 32 indexed citations
19.
Zhi, Qiaoming, Xiaobo Guo, Lei Guo, et al.. (2013). Oncogenic miR-544 is an Important Molecular Target in Gastric Cancer. Anti-Cancer Agents in Medicinal Chemistry. 13(2). 270–275. 29 indexed citations
20.
Jiang, Jinling, et al.. (2011). BEST of KAUST at TREC 2011: Building Effective Search in Twitter.. Text REtrieval Conference. 63(2). 167–71. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026